Corona Remedies Ltd CORONA.NS
₹2,041.10 ₹6.00 (0.29%) 1D
Last Updated: Oct 07, 12:00 AM·NSE
Pricing for IN stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Corona Remedies Ltd Stock Halal?
Shariah Compliance Analysis of CORONA.NS Stock
India Health Care Small Cap Yes. As of October 2026, Corona Remedies Ltd (CORONA.NS) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Corona Remedies Ltd passes Musaffa's business and financial screening criteria.
CORONA Remedies Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat and currently employs 4,508 full-time employees. The company went IPO on 2025-12-15. The firm is engaged in developing, manufacturing and marketing products in women’s healthcare, cardio-diabetes, pain management, urology and other/multispecialty pharmaceuticals (comprising vitamins/minerals/nutrition (VMN), gastrointestinal and respiratory). Its diverse product portfolio comprises approximately 67 brands catering to a range of therapeutic areas. The company has four dosage forms in pain management formulations, which it offers in the form of tablets, capsules, sprays and injections for treatments associated with musculoskeletal spasms and diabetes. The company holds brands across the women’s healthcare lifecycle, from adolescence to infertility, pregnancy, post-pregnancy and pre- and post-menopause categories. Its brands include such as C-HOP; Trazer; COR; Cortel; Rosuless; Bisobis; Sitabite; Dapabite; Fur; Voglibite; Angiwell; Stimucor; Argihope, and others.
CORONA.NS Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Corona Remedies Ltd is classified as halal.
HALALCorona Remedies Ltd (CORONA.NS) Chart
Fetching Price Chart...
Financial Metrics & Statements of Corona Remedies Ltd (CORONA.NS)
FAQ's for Corona Remedies Ltd (CORONA.NS)
- As of October 2026, Corona Remedies Ltd CORONA.NS is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corona Remedies Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Corona Remedies Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Corona Remedies Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Corona Remedies Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Corona Remedies Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Corona Remedies Ltd (CORONA.NS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
